%0 Journal Article
%T Transarterial infusion of epirubicin and cisplatin combined with systemic infusion of 5-fluorouracil versus transarterial chemoembolization using doxorubicin for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective analysis
%A Hae Lim Lee
%A Jeong Won Jang
%A Jong Young Choi
%A Jung Hyun Kwon
%A Nam Ik Han
%A Seung Kew Yoon
%A Si Hyun Bae
%A Soon Woo Nam
%A Sung Won Lee
%J Archive of "Therapeutic Advances in Medical Oncology".
%D 2017
%R 10.1177/1758834017728018
%X More than one-third of hepatocellular carcinoma (HCC) patients are diagnosed at advanced stage with portal vein tumor thrombosis (PVTT) or extrahepatic metastasis. However, the outcomes of current therapeutic approaches are unsatisfactory. As a novel therapeutic strategy for unresectable HCC with PVTT, we analyzed the outcomes of transarterial infusion of epirubicin and cisplatin combined with systemic infusion of 5-fluorouracil (TAC-ECF) and compared its therapeutic effects and toxicity with transarterial chemoembolization (TACE) using doxorubicin (DOX)
%K cisplatin
%K epirubicin
%K 5-fluorouracil
%K hepatocellular carcinoma
%K portal vein tumor thrombosis
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613859/